Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma

NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
May 04, 2018 09:29 ET | Source: Delcath Systems, Inc.

Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...
May 03, 2018 08:30 ET | Source: Delcath Systems, Inc.

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
May 01, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces Ratio for Reverse Split Authorization

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the...
April 09, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces Shareholder Approval of Consent Solicitation

NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
April 03, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
March 29, 2018 08:00 ET | Source: Delcath Systems, Inc.

Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia

NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that a...
March 19, 2018 16:05 ET | Source: Delcath Systems, Inc.

Delcath to Present at Oppenheimer 28th Annual Healthcare Conference

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...
March 16, 2018 09:00 ET | Source: Delcath Systems, Inc.

Delcath Announces 2017 Financial Results

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...
March 12, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath to Present at 30th Annual Roth Conference

NEW YORK, March 12, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that...